Compare CLH & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLH | VTRS |
|---|---|---|
| Founded | 1980 | 1961 |
| Country | United States | United States |
| Employees | N/A | 30000 |
| Industry | Environmental Services | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1B | 17.7B |
| IPO Year | 1994 | 2019 |
| Metric | CLH | VTRS |
|---|---|---|
| Price | $281.92 | $16.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $309.45 | $13.50 |
| AVG Volume (30 Days) | 585.8K | ★ 11.7M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.21% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.19 | 0.15 |
| Revenue | $2,944,978,000.00 | ★ $14,299,900,000.00 |
| Revenue This Year | $4.58 | $4.41 |
| Revenue Next Year | $4.30 | $1.96 |
| P/E Ratio | $235.35 | ★ $107.47 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $201.34 | $8.40 |
| 52 Week High | $316.98 | $17.53 |
| Indicator | CLH | VTRS |
|---|---|---|
| Relative Strength Index (RSI) | 38.84 | 51.86 |
| Support Level | $277.65 | $16.02 |
| Resistance Level | $296.41 | $16.38 |
| Average True Range (ATR) | 6.48 | 0.43 |
| MACD | -2.05 | -0.16 |
| Stochastic Oscillator | 8.64 | 8.90 |
Clean Harbors Inc is an environmental and industrial services provider that provides parts cleaning and related environmental services to commercial, industrial, and automotive customers. Its business segments are Environmental Services and Safety-Kleen Sustainability Solutions. Environmental Services includes waste collection, transportation, treatment, recycling, and disposal, along with industrial maintenance services. Safety-Kleen Sustainability Solutions provides used oil collection and manufactures base oil, vacuum gas oil, and lubricants. The company generates the majority of its revenues from the Environmental Services segment and operates in the United States, with maximum revenue, and Canada.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.